Clinical Mel B, resistance in Rhodesian sleeping sickness.
D001152:Arsenicals / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004671:Encephalitis, Arbovirus / Q000188:drug therapy*; D006801:Humans; D009583:Nitrofurazone / Q000627:therapeutic use*; D014227:Triazines / Q000627:therapeutic use; D014330:Tropical Medicine; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000188:drug therapy*; D015030:Zimbabwe
D001152:Arsenicals; D014227:Triazines; D014344:Trypanocidal Agents; D009583:Nitrofurazone